What does GTC Biotherapeutics invest in?
GTC Biotherapeutics invests most often at Series D (100% of the rounds on record), in sectors such as Biotechnology and Therapeutics.
GTC Biotherapeutics highlights
- 01
1 rounds on record
- 02
Mostly Series D: 100% of its rounds
- 03
1 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- BiotechnologyTherapeutics
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2004
1 round
- May
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Merrimack PharmaceuticalsListedUndisclosedMar 2012
An exit counts when it came after the firm's first round in the company. From historical deal records.